Literature DB >> 9988101

Methamphetamine alters prodynorphin gene expression and dynorphin A levels in rat hypothalamus.

P Romualdi1, A Donatini, A Capobianco, S Ferri.   

Abstract

Chronic administration of morphine or cocaine affects opioid gene expression. To better understand the possible existence of common neuronal pathways shared by different classes of drugs of abuse, we studied the effects of methamphetamine on the gene expression of the opioid precursor prodynorphin and on the levels of peptide dynorphin A in the rat brain. Acute (6 mg/kg, intraperitoneally, i.p.) and chronic (6 mg/kg, i.p. for 15 days) methamphetamine markedly raised prodynorphin mRNA levels in the hypothalamus, whereas no effect was observed in the hippocampus. Dynorphin A levels increased after chronic treatment in the hypothalamus and in the striatum, whereas no significant changes were detected after acute treatment. These results indicate that methamphetamine affects prodynorphin gene expression in the hypothalamus, which may be an important site (also for its relevant neuroendocrine correlates) for opioidergic mechanisms activated by addictive drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988101     DOI: 10.1016/s0014-2999(98)00905-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Regulation of opioid gene expression in the rat brainstem by 3,4-methylenedioxymethamphetamine (MDMA): role of serotonin and involvement of CREB and ERK cascade.

Authors:  Manuela Di Benedetto; Sussy del Carmen Bastías Candia; Claudio D'Addario; Elena Elettra Porticella; Chiara Cavina; Sanzio Candeletti; Patrizia Romualdi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-23       Impact factor: 3.000

2.  The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stress.

Authors:  Daniel E Rusyniak; Dmitry V Zaretsky; Maria V Zaretskaia; Pamela J Durant; Joseph A DiMicco
Journal:  Physiol Behav       Date:  2012-02-14

3.  Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.

Authors:  A Crocker; R A España; M Papadopoulou; C B Saper; J Faraco; T Sakurai; M Honda; E Mignot; T E Scammell
Journal:  Neurology       Date:  2005-09-14       Impact factor: 9.910

Review 4.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

5.  Hippocampal dynorphin immunoreactivity increases in response to gonadal steroids and is positioned for direct modulation by ovarian steroid receptors.

Authors:  A Torres-Reveron; S Khalid; T J Williams; E M Waters; L Jacome; V N Luine; C T Drake; B S McEwen; T A Milner
Journal:  Neuroscience       Date:  2008-12-24       Impact factor: 3.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.